Be Prepared to Treat and Prevent VTE Due to Cancer

You’ll continue to see a shift toward direct oral anticoagulants (Eliquis, etc) for cancer-associated venous thromboembolism (VTE).

For years, we’ve been using a low-molecular-weight heparin (LMWH), such as enoxaparin...with warfarin as an alternative.

But evidence with DOACs is stacking up for VTE due to cancer.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote